Palladone gets FDA approval

Share this article:
The FDA has approved Purdue Pharma's Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous opioid pain relief for an extended period of time.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION